WINTON GROUP Ltd Has $5.11 Million Stock Holdings in Avantor, Inc. $AVTR

WINTON GROUP Ltd lifted its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 797.6% during the 3rd quarter, Holdings Channel reports. The firm owned 409,558 shares of the company’s stock after purchasing an additional 363,928 shares during the quarter. WINTON GROUP Ltd’s holdings in Avantor were worth $5,111,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Sector Gamma AS lifted its stake in Avantor by 28.0% in the third quarter. Sector Gamma AS now owns 477,104 shares of the company’s stock valued at $5,954,000 after buying an additional 104,466 shares during the period. Greenhaven Associates Inc. acquired a new stake in shares of Avantor during the 3rd quarter worth approximately $228,528,000. Quantbot Technologies LP increased its stake in shares of Avantor by 1,333.0% in the 3rd quarter. Quantbot Technologies LP now owns 246,494 shares of the company’s stock valued at $3,076,000 after acquiring an additional 229,293 shares in the last quarter. Voss Capital LP acquired a new position in shares of Avantor during the 2nd quarter valued at $6,057,000. Finally, ABS Direct Equity Fund LLC acquired a new position in shares of Avantor during the 3rd quarter valued at $1,248,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Activity

In related news, Director Gregory L. Summe purchased 100,000 shares of the business’s stock in a transaction on Thursday, February 12th. The stock was acquired at an average price of $9.40 per share, for a total transaction of $940,000.00. Following the purchase, the director owned 400,000 shares of the company’s stock, valued at approximately $3,760,000. This trade represents a 33.33% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Gregory T. Lucier acquired 50,000 shares of the firm’s stock in a transaction on Thursday, February 19th. The shares were bought at an average cost of $9.16 per share, with a total value of $458,000.00. Following the completion of the acquisition, the director directly owned 50,000 shares in the company, valued at approximately $458,000. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. 1.20% of the stock is currently owned by company insiders.

Analyst Ratings Changes

AVTR has been the topic of several research analyst reports. TD Cowen reissued a “hold” rating on shares of Avantor in a research note on Thursday, February 12th. Barclays reiterated an “underweight” rating and set a $8.50 price objective on shares of Avantor in a report on Friday. Zacks Research cut shares of Avantor from a “hold” rating to a “strong sell” rating in a research report on Friday, February 13th. Jefferies Financial Group restated an “underperform” rating and issued a $8.00 target price on shares of Avantor in a research note on Thursday, February 12th. Finally, Robert W. Baird set a $11.00 target price on Avantor in a research report on Thursday, February 12th. Three equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $11.80.

Avantor Stock Performance

AVTR opened at $8.14 on Tuesday. Avantor, Inc. has a 1-year low of $7.82 and a 1-year high of $18.02. The company has a market cap of $5.55 billion, a price-to-earnings ratio of -10.43, a PEG ratio of 3.21 and a beta of 0.97. The company’s fifty day moving average price is $10.64 and its two-hundred day moving average price is $11.81. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The firm had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The business’s revenue was down 1.4% on a year-over-year basis. During the same period last year, the company earned $0.27 earnings per share. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, analysts expect that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.